Skeletal Muscle Damage in COVID-19: A Call for Action

Both laboratory investigations and body composition quantification measures (e.g., computed tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) patients. Muscle loss is associated with a poor prognosis of the disease. The exact mechanism of muscle damage in COVID-1...

Full description

Bibliographic Details
Main Authors: Amira Mohammed Ali, Hiroshi Kunugi
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/4/372
_version_ 1827695374925561856
author Amira Mohammed Ali
Hiroshi Kunugi
author_facet Amira Mohammed Ali
Hiroshi Kunugi
author_sort Amira Mohammed Ali
collection DOAJ
description Both laboratory investigations and body composition quantification measures (e.g., computed tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) patients. Muscle loss is associated with a poor prognosis of the disease. The exact mechanism of muscle damage in COVID-19 patients, as well as the long-term consequences of muscle injury in disease survivors, are unclear. The current review briefly summarizes the literature for mechanisms, assessment measures, and interventions relevant to skeletal muscle insult in COVID-19 patients. Muscle injury is likely to be attributed to the cytokine storm, disease severity, malnutrition, prolonged physical inactivity during intensive care unit (ICU) stays, mechanical ventilation, and myotoxic drugs (e.g., dexamethasone). It has been assessed by imaging and non-imaging techniques (e.g., CT and electromyography), physical performance tests (e.g., six-minute walk test), anthropometric measures (e.g., calf circumference), and biomarkers of muscle dystrophy (e.g., creatine kinase). Interventions directed toward minimizing muscle loss among COVID-19 patients are lacking. However, limited evidence shows that respiratory rehabilitation improves respiratory function, muscle strength, quality of life, and anxiety symptoms in recovering older COVID-19 patients. Neuromuscular electrical stimulation may restore muscle condition in ICU-admitted patients, albeit empirical evidence is needed. Given the contribution of malnutrition to disease severity and muscle damage, providing proper nutritional management for emaciated patients may be one of the key issues to achieve a better prognosis and prevent the after-effects of the disease. Considerable attention to longer-term consequences of muscle injury in recovering COVID-19 patients is necessary.
first_indexed 2024-03-10T12:24:28Z
format Article
id doaj.art-ce91d7e09ffa4e9290b3cdcc8edb380f
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T12:24:28Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-ce91d7e09ffa4e9290b3cdcc8edb380f2023-11-21T15:13:16ZengMDPI AGMedicina1010-660X1648-91442021-04-0157437210.3390/medicina57040372Skeletal Muscle Damage in COVID-19: A Call for ActionAmira Mohammed Ali0Hiroshi Kunugi1Department of Psychiatric Nursing and Mental Health, Faculty of Nursing, Alexandria University, Alexandria 21527, EgyptDepartment of Psychiatry, School of Medicine, Teikyo University, Tokyo 173-8605, JapanBoth laboratory investigations and body composition quantification measures (e.g., computed tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) patients. Muscle loss is associated with a poor prognosis of the disease. The exact mechanism of muscle damage in COVID-19 patients, as well as the long-term consequences of muscle injury in disease survivors, are unclear. The current review briefly summarizes the literature for mechanisms, assessment measures, and interventions relevant to skeletal muscle insult in COVID-19 patients. Muscle injury is likely to be attributed to the cytokine storm, disease severity, malnutrition, prolonged physical inactivity during intensive care unit (ICU) stays, mechanical ventilation, and myotoxic drugs (e.g., dexamethasone). It has been assessed by imaging and non-imaging techniques (e.g., CT and electromyography), physical performance tests (e.g., six-minute walk test), anthropometric measures (e.g., calf circumference), and biomarkers of muscle dystrophy (e.g., creatine kinase). Interventions directed toward minimizing muscle loss among COVID-19 patients are lacking. However, limited evidence shows that respiratory rehabilitation improves respiratory function, muscle strength, quality of life, and anxiety symptoms in recovering older COVID-19 patients. Neuromuscular electrical stimulation may restore muscle condition in ICU-admitted patients, albeit empirical evidence is needed. Given the contribution of malnutrition to disease severity and muscle damage, providing proper nutritional management for emaciated patients may be one of the key issues to achieve a better prognosis and prevent the after-effects of the disease. Considerable attention to longer-term consequences of muscle injury in recovering COVID-19 patients is necessary.https://www.mdpi.com/1648-9144/57/4/372coronavirus disease 2019COVID-19cytokine stormintensive care unit-acquired weaknessolder adultsaging
spellingShingle Amira Mohammed Ali
Hiroshi Kunugi
Skeletal Muscle Damage in COVID-19: A Call for Action
Medicina
coronavirus disease 2019
COVID-19
cytokine storm
intensive care unit-acquired weakness
older adults
aging
title Skeletal Muscle Damage in COVID-19: A Call for Action
title_full Skeletal Muscle Damage in COVID-19: A Call for Action
title_fullStr Skeletal Muscle Damage in COVID-19: A Call for Action
title_full_unstemmed Skeletal Muscle Damage in COVID-19: A Call for Action
title_short Skeletal Muscle Damage in COVID-19: A Call for Action
title_sort skeletal muscle damage in covid 19 a call for action
topic coronavirus disease 2019
COVID-19
cytokine storm
intensive care unit-acquired weakness
older adults
aging
url https://www.mdpi.com/1648-9144/57/4/372
work_keys_str_mv AT amiramohammedali skeletalmuscledamageincovid19acallforaction
AT hiroshikunugi skeletalmuscledamageincovid19acallforaction